Lipitor ( DrugBank: - )

3 diseases

51. 全身性強皮症

臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2005-003775-21-GB (EUCTR)	14/08/2008	10/11/2005	Effects of atorvastatin on microcirculatory endothelial function in patients with systemic sclerosis ...	Effects of atorvastatin on microcirculatory endothelial function in patients with systemic sclerosis ...	Systemic sclerosis (also termed 'scleroderma')	Trade Name: Lipitor Product Name: Lipitor	Salford Royal Hospitals NHS Trust	University of Manchester	Not Recruiting			Female: yes Male: yes	36	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United Kingdom

臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2009-010163-16-GB (EUCTR)	05/06/2009	18/08/2009	Bile salt manipulation as a novel treatment for Crohn’s disease: a single centre open label pilot st ...	Bile salt manipulation as a novel treatment for Crohn’s disease: a single centre open label pilot st ...	Active Crohn's disease affecting the ileum MedDRA version: 9.1;Level: LLT;Classification code 100114 ...	Trade Name: Lipitor Trade Name: Cholestagel	University College London	NULL	Not Recruiting			Female: yes Male: yes	13	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United Kingdom

臨床試験数 : 1,696 / 薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-022042-24-GB (EUCTR)	24/12/2010	25/10/2010	A Randomised Controlled Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis B ...	A Randomised Controlled Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis B ...	The aim of this randomized double blind controlled study is to evaluate the efficacy of a 3 months t ...	Trade Name: Lipitor Product Name: Atorvastatin INN or Proposed INN: Atorvastatin Other descriptive name ...	NHS Lothian	University of Edinburgh	Not Recruiting			Female: yes Male: yes	32	Phase 4	United Kingdom
2	EUCTR2010-022040-20-GB (EUCTR)	17/12/2010	21/10/2010	A Randomised Controlled Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis B ...	A Randomised Controlled Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis B ...	The aim of this randomised double blind controlled study to evaluate the efficacy of 6 months treatm ...	Trade Name: Lipitor Product Name: Atorvastatin INN or Proposed INN: Atorvastatin Other descriptive name ...	NHS Lothian	University of Edinburgh	Not Recruiting			Female: yes Male: yes	60	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United Kingdom